The election is nearing the finish line for states to enter their electoral votes by mid-December. Since then, COVID-19 continues to intensify and spread, and now two Senate elections in Georgia may determine how much the new president can accomplish,…

As part of our focus on being a trusted partner to 340B covered entities and simplifying compliance, Sentry Data Systems is proud to announce that its Sentinel platform now features fully seamless integration with each of the so-called ‘Big…

By the time you read this, much will have changed. A new Supreme Court Justice has been confirmed, shifting the political balance of the court. A presidential election will transpire shortly, with its many implications for the Affordable Care…

Safety net healthcare providers are under enormous pressure on multiple fronts these days. The 340B Drug Pricing Program is under assault from drug manufacturers, CMS’s proposed 340B reimbursement cuts are tied up in the courts and the COVID-19…

It’s important to understand that capturing referrals for eligible patients is 100% compliant with 340B regulations. So don’t let the complexities of managing referral provider relationships prevent you from realizing additional 340B benefit.

Learn how to maximize your 340B benefits and make the program work for you. The next round of our Foundations Certificate training program begins in November.

A deeper dive into strategies pharmaceutical companies have been cooking up to curtail the 340B program and skirt payment requirements.

In response to the COVID-19 pandemic, HRSA’s Office of Pharmacy Affairs has made a number of adjustments to its guidelines for the 340B drug pricing program for stakeholders.

We take a deeper dive into the moves pharma has been making and the executive order affecting FQHCs that we mentioned in previous blogs last month, discuss the long-awaited court decision about the Medicare part B reimbursement cuts, and we also take a look at HRSA’s new registration and recertification requirements.